Insiders · Profile

Apel Daniel Joseph

Chief Financial Officer at ARROWHEAD PHARMACEUTICALS. Filing since 22 Apr 2026. CIK 0002081169

Company
Date
Role
Action
Shares
Amount
Of holding
22 Apr 2026
Chief Financial Officer
Sold on a plan
13,095
$934.29K
7.4%
1 decision on file.